Table 3.
Model performances measured by iAUC in the overall survival prediction
| Model | iAUC | 95% CI | iAUC difference | 95% CI | p |
|---|---|---|---|---|---|
| Lung 1 training set | |||||
| Radiomics | 0.615 | 0.584–0.646 | |||
| Clinical | 0.549 | 0.511–0.587 | |||
| Radiomics + clinical | 0.621 | 0.588–0.654 | |||
| Radiomics + clinical vs. radiomics | 0.006 | −0.019–0.032 | 0.657 | ||
| Radiomics + clinical vs. clinical | 0.072 | 0.037–0.107 | < 0.001*** | ||
| Radiomics vs. clinical | 0.066 | 0.016–0.116 | 0.0082** | ||
| Lung 2 testing set | |||||
| Radiomics | 0.586 | 0.493–0.679 | |||
| Clinical | 0.687 | 0.600–0.775 | |||
| Radiomics + clinical | 0.736 | 0.654–0.819 | |||
| Radiomics + clinical vs. radiomics | 0.150 | 0.055–0.245 | 0.0018** | ||
| Radiomics + clinical vs. clinical | 0.049 | −0.009–0.106 | 0.09 | ||
| Radiomics vs. clinical | −0.101 | −0.239–0.036 | 0.149 | ||
| Kidney external validation set | |||||
| Radiomics | 0.719 | 0.598–0.84 | |||
| Clinical | 0.761 | 0.621–0.901 | |||
| Radiomics + clinical | 0.834 | 0.722–0.946 | |||
| Radiomics + clinical vs. radiomics | 0.116 | 0.004–0.227 | 0.041 * | ||
| Radiomics + clinical vs. clinical | 0.073 | −0.018–0.165 | 0.12 | ||
| Radiomics vs. clinical | −0.042 | −0.209–0.125 | 0.634 | ||
| Head & neck external validation set | |||||
| Radiomics | 0.643 | 0.563–0.722 | |||
| Clinical | 0.693 | 0.614–0.771 | |||
| Radiomics + clinical | 0.732 | 0.655–0.809 | |||
| Radiomics + clinical vs. radiomics | 0.089 | 0.016–0.163 | 0.016* | ||
| Radiomics + clinical vs. clinical | 0.039 | −0.013–0.091 | 0.149 | ||
| Radiomics vs. clinical | −0.05 | −0.151–0.051 | 0.331 | ||